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Down syndrome (DS) is the most common genetic disorder associated with mental
retardation. It has been repeatedly shown that Ts65Dn mice, the prime animal model
for DS, have severe cognitive and neural plasticity defects due to excessive inhibition.
We report that increasing sensory-motor stimulation in adulthood through environmental
enrichment (EE) reduces brain inhibition levels and promotes recovery of spatial memory
abilities, hippocampal synaptic plasticity, and visual functions in adult Ts65Dn mice.
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INTRODUCTION
Down syndrome (DS), a condition due to chromosome 21
trisomy (Lejeune et al., 1959), is the most common genetic cause
of mental retardation, with an incidence ranging from 1 in 700
to 1 in 1000 live births (Roizen and Patterson, 2003). Together
with cognitive disabilities (Nadel, 2003; Pennington et al., 2003),
people with DS exhibit a number of attention and sensory
deficits (Brown et al., 2003; Clark and Wilson, 2003), with well-
documented defects in basic visual functions (John et al., 2004).
In search for possible molecular and cellular processes involved in
the pathogenesis of the syndrome, several transgenic mousemod-
els of DS have been generated, carrying triplications of different
segments of the murine chromosome 16, which has a large degree
of synteny with the human chromosome 21 (Gardiner et al.,
2003; Seregaza et al., 2006; Moore and Roper, 2007). The most
widely studied model of DS is the Ts65Dn line, which sum-
marizes the main hallmarks of the DS phenotype, includ-
ing a serious cognitive impairment (Escorihuela et al., 1995;
Reeves et al., 1995; Holtzman et al., 1996; Hunter et al., 2003;
Stasko and Costa, 2004) and multiple deficits at the functional
and anatomical level in the visual system (Scott-McKean et al.,
2010; Blank et al., 2011).
Numerous studies have shown that the cognitive deficits
displayed by Ts65Dn mice are mainly related to excessive
levels of inhibition in the temporal lobe circuitries, with
a failure of long-term synaptic plasticity in the hippocam-
pus (e.g., Siarey et al., 1997, 1999; Kleschevnikov et al., 2004,
2011; Fernandez et al., 2007; see Baroncelli et al., 2011 for a
recent review). Accordingly, marked morphological changes in
inhibitory circuitries have been reported in the hippocampus and
in the cerebral cortex, with a selective enlargement of the active
zones of symmetric synapses and increased immunoreactivity for
synaptic proteins marking inhibitory synapses (Belichenko et al.,
2009; Perez-Cremades et al., 2010). Moreover, systemic adminis-
tration of non-competitive antagonists of GABAA receptors can
reverse spatial learning disabilities and long-term potentiation
(LTP) deficits in Ts65Dn mice (Fernandez et al., 2007).
Despite this evidence, however, it remains unknown whether
it is possible to ameliorate the phenotype of DS mouse mod-
els using non-invasive approaches more eligible for human
application. Evidence exists that environmental enrichment
(EE), a condition of increased sensory-motor stimulation
(van Praag et al., 2000; Sale et al., 2009), has remarkably ben-
eficial effects in animal models of nervous system disor-
ders, including neurodegenerative and developmental diseases
(for comprehensive reviews, see Nithianantharajah and Hannan,
2006; Baroncelli et al., 2010a). It has been demonstrated that
exposing Ts65Dn mice to EE improves their memory abilities
(Martínez-Cué et al., 2002, 2005), affects the structure of cortical
pyramidal cells (Dierssen et al., 2003) and, at the molecular level,
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restores the G-protein-associated signal transduction systems
(Baamonde et al., 2011). Moreover, a combination of EE and
physical exercise increases cell proliferation, neurogenesis, and
gliogenesis in the hippocampus and the forebrain subventricu-
lar zone (Chakrabarti et al., 2011). Very little is instead known on
the EE impact at the level of neural functions in the hippocampus
and cerebral cortex of DS mouse models.
Using the visual system as a paradigm for the study of
experience-dependent plasticity, we have recently demonstrated
that EE can be efficiently employed to reduce cortical inhi-
bition (Sale et al., 2007; Baroncelli et al., 2010b), enhancing
neuronal plasticity in the adult brain. Thus, EE could be par-
ticularly suitable for the treatment of pathologies linked to
disruption of the GABAergic tone. Given that results obtained
in postmortem tissue suggest that people with DS have an
impaired balance between excitatory and inhibitory systems (see
Rissman and Mobley, 2011 for a recent review), here we choose
to investigate the effects elicited by EE on Ts65Dn mice, the
DS model in which this alteration has been characterized most
extensively. We report that EE reduces GABA release in the hip-
pocampus and the visual cortex of Ts65Dn mice and is highly
effective in favoring recovery of spatial learning, hippocampal
LTP, and visual acuity.
MATERIALS AND METHODS
All the procedures employed in this study were approved by the
Italian Ministry of Public Health.
ANIMALS
Segmental trisomy 16 (Ts65Dn) mice (Jax West Laboratories,
Davis, CA) were obtained by mating female carriers of the
1716 chromosome (B6EiC3H – a/ATs65Dn) with (C57BL/6JEi ×
C3H/HeJ)F1 (JAX # JR1875)males. Ts65Dnmice were thusmain-
tained on the B6/C3H background. Wild-type (WT) (euploid
littermates of Ts65Dn mice) and Ts65Dn mice arriving from Jax
Laboratories were housed in plexiglas cages, kept on a 12 h/12 h
light-dark cycle and acclimated to these controlled housing con-
ditions for at least one week before inclusion in the study. A total
of 39 WT and 44 Ts65Dn mice of both genders were used in this
study. In all experiments we included in the analysis both WT and
trisomic pups of the same litters.
GENOTYPING
All WT and Ts65Dn mice were genotyped using real-time
quantitative PCR (qPCR) with TaqMan probes (Applied
Biosystems) specific for amyloid ß precursor protein gene (App),
apolipoprotein B gene (Apob), and myxovirus resistance 1 gene
(Mx1). The sequences of primers and probes were as follows:
ApoB Probe: 5′-CCAATGGTCGGGCACT-3′; ApoB F: 5′-
CACGTGGGCTCCAGCATT-3′; ApoB R: 5′-TCACCAGTCA
TTTCTGCCTTTG-3′;
App Probe: 5′-CCATCATCGGACTCAT-3′; App F: 5′-
TGCTGAAGATGTGGGTTCGA-3′; App R: 5′-GACAATCA
CGGTTGCTATGACAA-3′;
Mx1 Probe: 5′-TGGCTTTCCTGGTCGC-3′; Mx1 F: 5′-
TCTCCGATTAACCAGGCTAGCTAT-3′; Mx1 R: 5′-GACA
TAAGGTTAGCAGCTAAAGGATCA-3′
Genes for App andMx1were used as the target (marker) genes,
whereas the ApoB gene was used as the internal control. The
rationale is that App and Mx1 are located in the chromosome
segment triplicated in Ts65Dn, whereas ApoB is mapped on chro-
mosome 12. Thus, Ts65Dn samples have three copies of App and
Mx1, whereas euploid samples have only two copies. Both Ts65Dn
and euploid animals have two copies of ApoB. The extra copy of
App orMx1 in trisomic samples is detected by qPCR. After ampli-
fication, the average change in cycle threshold (CT) of the
target gene App/Mx1 from that of ApoB in sample animals with
respect to controls was calculated (CT = (CTApp/Mx1 −
CTApoB)trisomic − (CTApp/Mx1 − CTApoB)euploid). The CT
value for App or Mx1 in trisomic samples is <−0.3.
WT and Ts65Dn mice were also genotyped for the retinal
degeneration (rd) allele before being submitted to experimenta-
tion; Rd–/– homozygotes were excluded from the study.
REARING ENVIRONMENTS
Adult WTmice of postnatal age> 60 days (P60) were maintained
in standard conditions (non-EE) consisting of a standard labora-
tory cage (26 × 42 × 18 cm) housing amaximumof three females
or brother males. Age-matched Ts65Dn mice were reared for six
weeks in either EE or in non-EE cages. EE consisted of a large cage
(44 × 62 × 28 cm) with a wire mesh lid containing several food
hoppers, running wheels, and differently shaped objects (e.g.,
tunnels, shelters, stairs) that were repositioned twice per week and
completely substituted with others once per week. Every EE cage
housed at least six females; since it is known that Ts65Dn males
have a tendency toward social subordination and that an excess of
social stimulation can disturb their behavioral and learning skills
(Martínez-Cué et al., 2005), we used a protocol of EE in which
only 2–3 Ts65Dn males from the same litter were reared together.
Litter and food were the same in both experimental conditions;
food and water were available ad libitum.
MORRIS WATER MAZE
Mice (n = 9 WT, n = 6 Ts65Dn-non-EE mice and n = 5
Ts65Dn-EE mice) were trained for two trials per day and for
a total of 10 days in a circular water tank, made from gray
polypropylene (diameter, 100 cm; height, 40 cm), filled to a depth
of 25 cm with water (23◦C) rendered opaque by the addition of a
small amount of atoxic white paint. Four positions around the
edge of the tank were arbitrarily designated North (N), South
(S), East (E), and West (W), which provided four alternative
start positions and also defined the division of the tank into
four quadrants: NE, SE, SW, and NW. To avoid possible con-
founding effects due to reduced visual acuity in Ts65Dn mice,
the tank was surrounded by a set of extra-maze cues in the visual
discrimination range detectable by all the three groups. A circu-
lar clear Perspex escape platform (diameter, 10 cm; height, 2 cm)
was submerged 0.5 cm below the water surface and placed at the
midpoint of one of the four quadrants. The hidden platform
remained in the same quadrant during training, while the start
positions (N, S, E, orW)were randomized across trials. Mice were
allowed up to 60 s to locate the escape platform, and their escape
latency was automatically recorded by the Noldus Ethovision sys-
tem. On the last trial of the last training day, mice received a
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single probe trial, during which the escape platform was removed
from the tank and the swimming paths were recorded over 60 s
while mice searched for the missing platform; the swimming
paths were recorded and analyzed with the Noldus Ethovision
system.
LTP RECORDINGS
Brains were rapidly removed and immersed in ice-cold cutting
solution containing (in mM): 130 NaCl, 3.1 KCl, 1.0 K2HPO4,
4.0 NaHCO3, 5.0 dextrose, 2.0 MgCl2, 1.0 CaCl2, 10 HEPES, 1.0
ascorbic acid, 0.5 myo-Inositol, 2.0 pyruvic acid, and 1.0 kynure-
nate, pH 7.3. Transverse slices (400µm thick) from the mid to
temporal pole of both hippocampi were obtained using a tissue
chopper. Slices (n = 12 slices and eight animals for WT, n = 13
slices and seven animals for Ts65Dn-non-EE mice, and n = 10
slices and five animals for Ts65Dn-EE mice) were allowed to
equilibrate at room temperature for at least 1.5 h before being
transferred to a recording interface chamber and perfused at a
rate of 4ml/min with 30◦C oxygenated recording solution. The
recording solution was composed as the cutting solution with the
following differences (in mM): 1.0MgCl2, 2.0 CaCl2, 0.01 glycine,
and no kynurenate. Electrical stimulation (100µsec duration)
was delivered with a bipolar concentric stimulating electrode
(FHC, St. Bowdoinham, ME) placed in the middle third of the
molecular layer∼400µm from the recording electrode. Dendritic
field excitatory post-synaptic potentials (fEPSPs) were recorded
by amicropipette (1–3M) filled with the recording solution and
positioned in the middle third of the molecular layer. Baseline
responses were obtained every 30 s with a stimulation intensity
that yielded a half-maximal response. After achievement of a
15min stable baseline (field potential amplitude within 15% of
change and with no evident increasing or decreasing trends), LTP
was induced by a high frequency stimulation (HFS) consisting
of four 100Hz, 0.5 s trains each separated by 30 s. Field record-
ings were filtered and digitized with an A/D board (National
Instruments) driven by a custom acquisition software. LTP graphs
were generated by averaging the amplitude of the fEPSPs in
2min bins, and expressing data as a percentage of the averaged
baseline collected before LTP induction.We evaluated field poten-
tial potentiation for each group by comparing the last 20min
post-HFS to baseline.
IN VIVO ELECTROPHYSIOLOGY
Mice (n = 13 WT, n = 6 Ts65Dn-non-EE mice and n = 5
Ts65Dn-EE mice) were anesthetized by i.p. injection with Zoletil-
100 (40mg/kg, Virbac), and Xilor (10mg/kg, Sigma) and placed
in a stereotaxic frame. Additional doses of the anesthetic were
used to keep the anesthesia level stable throughout the experi-
ment. Body temperature was continuously monitored and main-
tained at ∼37◦C by a thermostated electric blanket. A hole was
drilled in the skull, corresponding to the binocular portion of the
primary visual cortex (V1) (binocular area Oc1B). After exposure
of the brain surface, a micropipette filled with NaCl (3M) was
inserted into the cortex 2.8–3.2mm from λ (intersection between
sagittal and lambdoid sutures). Both eyes were fixed and kept
open by means of adjustable metal rings surrounding the exter-
nal portion of the eye bulb. The eyes were frequently inspected
and rinsed with physiological solution to prevent the formation
of cataracts. Visual acuity through both eyes was measured using
visual evoked potentials (VEPs). To record VEPs, the electrode
was advanced at a depth of 100 or 400µm within the cortex. At
these depths, VEPs had their maximal amplitude. Signals were
band-pass-filtered (0.1–100Hz), amplified, and fed to a computer
for analysis. At least 50 events were averaged in synchrony with the
stimulus contrast reversal. Transient VEPs in response to abrupt
contrast reversal (1Hz) were evaluated in the time domain by
measuring the peak-to-baseline amplitude and peak latency of the
major positive (at 100µm depth) or negative (at 400µm depth)
component. Visual stimuli were horizontal sinusoidal gratings of
different spatial frequencies, generated by a VSG2/2 card running
custom software and presented on a monitor (20 × 22 cm; lumi-
nance 15 cd/m2) positioned 20 cm from the mouse eyes. Visual
acuity was obtained by extrapolation to zero amplitude of the
linear regression through the data points in a curve where VEP
amplitude is plotted against log spatial frequency. Binocularity
was assessed calculating the contralateral to ipsilateral (C/I) VEP
ratio at 0.05 cycles per degree (c/deg), i.e., the ratio of VEP ampli-
tudes recorded by stimulating the contralateral and ipsilateral eye
with respect to the brain side where recording is performed. For
each animal, at least 12 independent C/I VEP ratio values were
calculated and averaged together from three well-spaced traces
along the medio-lateral and antero-posterior axes of the V1. Care
was taken to equally sample VEPs across the two cortical depths
so that all layers contributed to the analysis.
ANALYSIS OF GABA RELEASE IN HIPPOCAMPAL AND VISUAL
CORTEX SYNAPTOSOMES
Animals (n = 16 WT, n = 10 Ts65Dn-non-EE mice and n = 7
Ts65Dn-EE mice) were sacrificed and the brain regions corre-
sponding to the V1 and to the hippocampus were removed.
Synaptosomes were prepared essentially as previously described
(Stigliani et al., 2006). The tissue was homogenized at 4◦C, uti-
lizing a homogenizer Teflon/glass (clearance 0.25mm), in 10
volumes of sucrose 0.32M, buffered with Tris-HCl at pH 7.4. The
homogenized tissue was centrifuged (5 min, 1000 × g a 4◦C) in
order to remove all nuclei and cellular fragments. Then, the super-
natant was gently stratified on a discontinuous Percoll gradient
(2, 6, 10, 20% v/v in tris HCl/sucrose) and again centrifuged
(33,500 × g per 5min a 4◦C). After centrifugation, the stratified
fraction of synaptosomes, leaning between 10% and 20% Percoll,
was collected, washed by centrifugation (20,200 × g per 15min a
4◦C), and then resuspended in a physiologic medium, contain-
ing: NaCl 140mM; KCl 3mM; MgCl2 1.2mM; CaCl2 1.2mM;
NaH2PO4 1.2mM; HEPES 10mM; glucose 10mM; pH 7.4.
Synaptosomes were incubated at 37◦C for 15min with the
radioactive tracers [3H]D-GABA, at a final concentration of
0.05µM (plus 50µM of the GABA transaminase inhibitor
amino-oxyacetic acid). Aliquots of the synaptosomal suspensions
were layered on microporous filters at the bottom of a set of
parallel superfusion chambers (Superfusion System, Ugo Basile,
Comerio, Varese, Italy; Raiteri et al., 1984) maintained at 37◦C.
Superfusion was started at a rate of 0.5ml/min with standard
medium supplemented with 50µM amino-oxyacetic acid. After
36min of superfusion, to equilibrate the system, samples were
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collected according to the following scheme: one sample collected
for 3min (t = 36–39min; basal outflow); one sample collected
for 6 min (t = 39–45min; stimulus-evoked release); one sample
collected for 3min (t = 45–48min; basal outflow after stimulus-
evoked release). A 90 s period of stimulation was applied at t =
39min, after the first sample has been collected. Stimulation
of synaptosomes was performed with 15mM KCl, substituting
for equimolar concentration of NaCl. Radioactivity was deter-
mined in each sample collected and superfused filters by liquid
scintillation counting. Tritium released in each sample was cal-
culated as percentage of the total synaptosomal tritium content
at the beginning of the respective sample collection (fractional
rate × 100). The stimulus-evoked overflow was estimated by sub-
tracting transmitter content of the two 3min samples (basal
outflow) from release evoked in the 6min sample collected during
and after the depolarization pulse (stimulus-evoked release).
STATISTICS
All statistical analysis was done using SigmaStat Software.
Differences between two groups were assessed with a two-tailed
t-test. One-Way ANOVA, Two-Way ANOVA, and Two-Way RM
ANOVA, followed by Holm–Sidak multiple comparison proce-
dure, were used to compare data belonging to three groups. Level
of significance was p < 0.05, unless otherwise specified. No dif-
ference emerged between data obtained in enriched male and
female Ts65Dn mice for latency in finding the platform on the
last day of training in the Morris water maze (MWM) task (t-test,
p = 0.185) and in the time exploring the target quadrant dur-
ing the probe session (t-test, p = 0.278), for hippocampal level
of LTP (Two-Way RM ANOVA, p = 0.256), visual acuity (t-test,
p = 0.678), ocular dominance (p = 0.526), and GABA release in
brain synaptosomes (Two-Way ANOVA, p = 0.215). Since male
and female data did not differ, they have been combined together
for further analysis.
RESULTS
SPATIAL MEMORY
We first assessed spatial memory abilities in the MWM task,
a cognitive paradigm in which Ts65Dn mice are known to
be severely impaired (Escorihuela et al., 1995; Stasko and Costa,
2004; Fernandez et al., 2007). We found that the while the latency
to locate the submerged platform on the ninth day of training
was longer in Ts65Dn mice reared in standard environmental
conditions (Ts65Dn-non-EE mice, 33.02 ± 8.24 s) compared to
both WT (14.52 ± 3.34 s) and Ts65Dn enriched mice (Ts65Dn-
EE mice, 15.61 ± 2.53 s), these two latter groups did not differ
between each other (Figure 1A). To assess the strength of spatial
learning we performed a probe trial in which the hidden platform
was removed and the amount of time spent in the former region
of platform was measured. The probe test confirmed the spatial
memory impairment of Ts65Dn mice: WT mice spent signifi-
cantly longer time in the quadrantwhere the platformwas located
during the previous learning days; in contrast, Ts65Dn-non-EE
mice showed no preference for the target quadrant (Figure 1B),
indicating that they did not remember the location of the hidden
platform. Also in this case, EE was able to completely counteract
the cognitive deficit displayed by Ts65Dn mice (Figure 1B).
A
B
FIGURE 1 | Environmental enrichment promotes spatial learning in
Ts65Dn mice. (A) Learning curves for WT (black) and Ts65Dn mice
maintained in standard (Ts65Dn-non-EE, white) or enriched (Ts65Dn-EE,
gray) environmental conditions. The histogram shows latency to locate the
submerged platform on the last day of training for the three groups.
One-Way ANOVA followed by a multiple comparison procedure
(Holm–Sidak method) showed a statistical difference between WT and
Ts65Dn-non-EE mice, but not between WT and Ts65Dn-EE mice
(p = 0.885). Inset is an example of swimming path during the last day of
training for a Ts65Dn-EE mouse. (B) Probe trial. Two-Way RM ANOVA
revealed a statically significant interaction between the genotype group and
the pool quadrant (p < 0.001). A Holm–Sidak multiple comparison
procedure revealed that while Ts65Dn-non-EE did not show any preference
for the target (NW) quadrant, both WT and Ts65Dn-EE mice spent
significantly more time in the NW quadrant than in the other quadrants.
Moreover, the time spent in the target quadrant was shorter in
Ts65Dn-non-EE mice than in the other two groups, which instead did not
differ between each other (p = 0.1). Inset shows an example of swimming
path during the probe session for a Ts65Dn-EE mouse.
*Statistical significance. Error bars, s.e.m.
SYNAPTIC PLASTICITY IN THE HIPPOCAMPUS
Since the spatial memory impairment displayed by Ts65Dn mice
has been repeatedly related to synaptic plasticity deficits in the
hippocampus (e.g., Siarey et al., 1997, 1999; Kleschevnikov et al.,
2004; Fernandez et al., 2007), we studied LTP in the dentate
gyrus in response to HFS of the perforant path, the circuitry
most severely affected by excessive levels of inhibition in the
Ts65Dn mouse brain (Belichenko et al., 2004; Fernandez et al.,
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2007; Kleschevnikov et al., 2011). While we found a strong
potentiation of the response after HFS in the dentate gyrus
of WT mice (132.04 ± 7.13%), no potentiation of fEPSPs
with respect to baseline was recorded in Ts65Dn-non-EE mice
(105.38 ± 5.85%). In contrast, a robust rescue of LTP was evident
in Ts65Dn-EE mice (124.5 ± 7.67%) (Figure 2). These results
demonstrate for the first time that EE in adult Ts65Dn mice can
restore long-term synaptic plasticity in a neural circuit critically
involved in spatial learning and memory.
VISUAL FUNCTIONS
It has been recently reported that Ts65Dn mice exhibit a num-
ber of visual deficits similar to those reported in individuals
with DS (Scott-McKean et al., 2010). Therefore, we moved to the
visual system with the aim to investigate whether the beneficial
effects exerted by EE are specific to the hippocampus or they are
also detectable in the sensory cortices. Using electrophysiologi-
cal recordings of VEPs from the V1, we measured visual acuity
of WT, Ts65Dn-non-EE, and Ts65Dn-EE mice and, for the first
time in this model, we analyzed the ocular dominance proper-
ties of visual cortical neurons calculating the C/I VEP ratio as
an index of V1 binocularity (see Sale et al., 2007). Visual acu-
ity of Ts65Dn-non-EE mice was lower (0.45 ± 0.04 c/deg) than
that of WT controls (0.57 ± 0.02 c/deg) (Figure 3A). While it
is well known that the C/I VEP ratio is in the 2.0–3.0 range
in adult normal mice (Porciatti et al., 1999), reflecting the pre-
dominance of crossed fibers in retinal projections, we found
that the visual cortex of Ts65Dn-non-EE mice was not domi-
nated by the contralateral eye, with a marked reduction in C/I
VEP ratio compared to WT animals (Figure 3B; C/I VEP ratio
of Ts65Dn-non-EE mice: 1.26 ± 0.18; C/I VEP ratio, WT mice:
2.36 ± 0.16). Moreover, we also report, in agreement with data
from patients with DS, that Ts65Dn-non-EE mice did also display
a robust increase in VEP latencies compared to WT controls in
response to visual gratings of 0.05, 0.1, 0.2, 0.3, and 0.4 spatial fre-
quencies (Figure 3C) (WT 0.05: 125.99 ± 3.28ms; 0.1: 130.56 ±
5.92ms; 0.2: 146.24 ± 9.26ms; 0.3: 144.18 ± 8.85ms; 0.4: 147.24
± 8.72ms. Ts65Dn-non-EE 0.05: 132.79 ± 9.51ms; 0.1: 145.33 ±
16.38ms; 0.2: 152.42± 8.04ms; 0.3: 161.03± 4.12ms; 0.4: 168.27
± 12.89ms).
EE completely reversed all visual function deficits displayed by
Ts65Dn mice (Figures 3A–C): the visual acuity (0.59 ± 0.06) and
the C/I VEP ratio (2.81 ± 0.27) of Ts65Dn-EE mice, indeed, were
not statistically different from those of WT mice; in addition, we
found that VEP latencies in Ts65Dn-EE mice were significantly
shorter than of Ts65Dn-non-EE mice, but did not differ from
FIGURE 2 | Recovery of long-term potentiation (LTP) at medial perforant
path–granule cell synapses in Ts65Dn mice reared in environmental
enrichment. Averaged data for LTP induced in WT (black circles),
Ts65Dn-non-EE (white circles) and Ts65Dn-EE mice (gray circles). Only slices
from WT and Ts65Dn-EE mice showed potentiation of the response after
high frequency stimulation (HFS) (Two-Way RM ANOVA, baseline vs. the last
20min post-HFS, p < 0.001), while slices from Ts65Dn-non-EE did not show
potentiation (Two-Way RM ANOVA, baseline vs. the last 20min post-HFS,
p = 1). A multiple comparison procedure (Holm–Sidak method) showed a
statistical difference in LTP levels between WT and Ts65Dn-non-EE mice,
between Ts65Dn-non-EE mice and Ts65Dn-EE mice and between WT and
Ts65Dn-EE mice (p < 0.001). Sample traces (vertical scale bar: 200µV;
horizontal scale bar: 2ms) from the three experimental groups before
(baseline) and after HFS (post-HFS) are also reported. The arrow
indicates HFS.
*Statistical significance; error bars, s.e.m.
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A
B C
FIGURE 3 | Restoration of visual functions in Ts65Dn mice by
environmental enrichment. Visual acuity (A), ocular dominance (B) and
peak latency (C) assessed by electrophysiological recordings of visual evoked
potentials (VEPs) from the primary visual cortex in WT (black),
Ts65Dn-non-EE, (white), and Ts65Dn-EE (gray) mice. One-Way ANOVA
showed that a statistical difference in the mean values was present among
the three groups for both visual acuity and C/I VEP ratio (p < 0.05 and
p < 0.001, respectively); a multiple comparison procedure (Holm–Sidak
method) showed a statistical difference between WT and Ts65Dn-non-EE
mice and between Ts65Dn-non-EE mice and Ts65Dn-EE mice, but not
between WT and Ts65Dn-EE mice (p = 0.82 for visual acuity;
p = 0.14 for C/I VEP ratio). VEP latencies of Ts65Dn-EE mice were
statistically different from Ts65Dn-non-EE animals, but not from WT mice
(Two-Way RM ANOVA). Representative examples of electrophysiological
visual acuity assessment of the three experimental groups are also
reported on the right of the (a) panel. Visual acuity was obtained by
extrapolation to zero amplitude of the linear regression through the data
points in a curve where VEP amplitude is plotted against log spatial
frequency.
*Statistical significance; error bars, s.e.m.
those recorded in WT controls (Figure 3C) (Ts65Dn-EE 0.05:
115.35 ± 16.50ms; 0.1: 126.33 ± 12.83ms; 0.2: 132.25 ± 9.56ms;
0.3: 132.93 ± 10.04ms; 0.4: 137.30 ± 10.83ms).
GABA RELEASE IN THE HIPPOCAMPUS AND IN THE VISUAL CORTEX
Because substantial evidence suggests that excessive inhibi-
tion is critically involved in the cognitive deficits displayed
by Ts65Dn mice (Siarey et al., 1997, 1999; Kleschevnikov et al.,
2004; Fernandez et al., 2007), we investigated whether restora-
tion of spatial learning abilities and dentate gyrus long-term
plasticity elicited by EE was accompanied by a reduced GABA
release in the hippocampus. Specifically, KCl-evoked release of
[3H]GABA from synaptosomes in superfusion was measured in
the hippocampus of WT, Ts65Dn a-non-EE and Ts65Dn-EE mice
(Figure 4A). Moreover, since we previously showed that EE is
able to reinstate plasticity in the visual cortex of adult animals
through a reduction of GABAergic inhibition (Sale et al., 2007;
Baroncelli et al., 2010b), we also performed synaptosome analysis
for GABA release in the V1 of the same animals (Figure 4B). We
found that the stimulus-evoked release of GABA was markedly
increased in both the hippocampus and the visual cortex of
Ts65Dn-non-EE mice (hippocampus: 7.30 ± 0.85%; visual cor-
tex: 10.63 ± 0.85%) compared to WT animals (hippocampus:
4.71 ± 0.67%; visual cortex: 7.26 ± 0.90%).
In contrast, levels of depolarization-evoked overflow of GABA
were markedly decreased in Ts65Dn-EE animals (hippocampus:
5.04 ± 1.02%; visual cortex: 7.22 ± 1.20%) and did not statisti-
cally differ from those of WT mice.
DISCUSSION
Our findings show that EE can be successfully employed to favor
recovery from cognitive impairment, synaptic plasticity failure,
and visual deficits in the most characterized mouse model of DS,
the Ts65Dn line. Moreover, we also report that levels of GABA
release are markedly increased in the hippocampus and in the
visual cortex of Ts65Dn mice compared to WT animals, and
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BA
FIGURE 4 | Depolarization-evoked release of GABA from synaptosomes.
Insert depicts the synaptosome technique. 15mM KCl evoked GABA
release from hippocampal (A) and visual cortex (B) synaptosomes of
wild-type (WT, black), Ts65Dn-non-EE (white) and Ts65Dn-EE (gray) mice.
Two-Way ANOVA showed a significant difference among the different levels
of group (p = 0.001); a multiple comparison procedure (Holm–Sidak method)
showed that levels of GABA were significantly higher, for both the
hippocampus and the visual cortex, in Ts65Dn non-enriched mice compared
to WT animals, while no statistical difference was present between Ts65Dn
enriched animals and WT mice (p = 0.79 for the hippocampus, p = 0.98 for
the visual cortex).
*Statistical significance; error bars, s.e.m.
that exposure to EE reduces the inhibitory transmission, bring-
ing GABA release in the synaptosomes of trisomic mice back to
WT control levels.
These results provide support to the idea that excessive inhi-
bition is a cellular mechanism at the core of the pathogenesis
of DS (Fernandez and Garner, 2007). To date, enhanced levels of
inhibition in Ts65Dnmice have been mainly documented electro-
physiologically. A main finding of the present work is to provide
an independent evidence of excessive GABAergic transmission in
the hippocampus of Ts65Dn mice using the biochemical model
of synaptosome neurotransmitter release analysis. Furthermore,
given that increased levels of depolarization-evoked overflow of
GABA were also found in the V1, our results suggest that excessive
GABAergic transmission might be a more general feature of the
Ts65Dn mouse brain, offering an attractive explanation for a
number of other functional deficits characterizing DS.
We also showed, in agreement with recent data by
Scott-McKean et al. (2010), a robust visual acuity decrease
in Ts65Dn mice. Considering that in people with DS the use of
corrective lenses does not eliminate major part of their visual
deficits (John et al., 2004), it remains unknown whether in
addition to anatomical eye abnormalities leading to refractive
errors (myopia, for instance, is more common in persons with DS
than in the general population; e.g., Shapiro and France, 1985;
Liyanage and Barnes, 2008), more subtle functional changes are
present at the level of V1 neural connections. In favor of this
latter possibility, we report for the first time an alteration in V1
ocular dominance measured in Ts65Dn mice using calculation
of C/I VEP ratio. This alteration is reminiscent of the effects
elicited by amblyopia (lazy eye) (Holmes and Clarke, 2006), a
condition frequently reported in people with DS (Tsiaras et al.,
1999) leading to poor visual acuity and successfully revertible
in adult rodents by enhancing brain plasticity through exposure
to EE conditions (Sale et al., 2007). Therefore, it is possible that
the increased environmental stimulation provided by EE might
compensate the functional deficits of Ts65Dn mice through a
potentiation of neuronal plasticity processes. In line with this
interpretation, Ts65Dn mice reared in EE conditions displayed
a marked reduction of GABA levels in the visual cortex, a
factor crucially involved in the reopening of cortical plasticity in
the adult brain (Sale et al., 2007; Maya Vetencourt et al., 2008;
Spolidoro et al., 2009; Harauzov et al., 2010).
Our results clearly indicate the possibility to ameliorate, in
adulthood, neurological phenotypes associated with early neu-
rodevelopmental disorders, a concept that is attracting a large
interest for its potential in clinical application (Ehninger et al.,
2008; Silva and Ehninger, 2009; Sale et al., 2010). Reducing
inhibition levels with pharmacological treatments has already
been shown to promote recovery from cognitive impairment
in Ts65Dn mice (Fernandez et al., 2007; Rueda et al., 2008).
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However, concerns can be raised on the effective clinical utility of
GABAA receptor antagonists in persons with DS. As thoroughly
discussed by Fernandez et al. (2007), indeed, some drugs (e.g.,
picrotoxin) are of very limited utility for their pro-convulsive
action, a condition particularly dangerous for DS patients, which
are more prone to convulsions (see Menendez, 2005), while
others, such as bilobalide or pentylenetetrazole, have not been
approved by the FDA. EE has the great advantage of reducing
inhibition avoiding the negative side effects induced by pharma-
cological treatments.
CONCLUSIONS
The present data indicate how dramatic can be the influence
exerted by environmental conditions on brain and behavior. The
EE capability to affect GABA release and to promote cognitive
and sensory function recovery in a totally non-invasive way
makes this paradigm eligible for application in the field of DS
therapy. It remains an open issue to what extent is EE in ani-
mal models relevant for the human being experience. Although
most humans do experience a high degree of environmental
complexity and novelty, levels of cognitive, social, and phys-
ical stimulation can vary greatly among individuals, particu-
larly in subjects affected by neurological diseases. Our results
encourage the development of intervention protocols based on
enriched experience aimed at promoting an active lifestyle in
DS people.
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